G Medical Innovations Holdings Ltd. (GMVD)
NASDAQ: GMVD · IEX Real-Time Price · USD
0.403
+0.004 (1.00%)
At close: Aug 19, 2022 3:35 PM
0.399
-0.004 (-0.968%)
After-hours:
Aug 19, 2022 4:38 PM EDT
GMVD Market Cap
GMVD has a market cap or net worth of $9.75 million as of August 19, 2022, making it the 6,165th biggest public company listed in the US. GMVD's market cap has decreased by -70.18% in one year.
Market Cap
9.75M
Enterprise Value
12.04M
1-Year Change
-70.18%
Ranking
Category
Nano-Cap
Stock Price
$0.403
Market Cap Chart
Since the IPO on June 25, 2021, GMVD's market cap has decreased from $64.57 million to $9.75 million, a decrease of -84.90%. That is a compound annual growth rate of -80.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 19, 2022 | 9.75M | 1.00% |
Aug 18, 2022 | 9.65M | 3.72% |
Aug 17, 2022 | 9.31M | - |
Aug 16, 2022 | 9.31M | -0.29% |
Aug 15, 2022 | 9.33M | -1.20% |
Aug 12, 2022 | 9.45M | -2.91% |
Aug 11, 2022 | 9.73M | 6.43% |
Aug 10, 2022 | 9.14M | 4.13% |
Aug 9, 2022 | 8.78M | -7.59% |
Aug 8, 2022 | 9.50M | -6.30% |
Aug 5, 2022 | 10.14M | -3.22% |
Aug 4, 2022 | 10.48M | 8.62% |
Aug 3, 2022 | 9.64M | 7.77% |
Aug 2, 2022 | 8.95M | 3.44% |
Aug 1, 2022 | 8.65M | 0.99% |
Jul 29, 2022 | 8.57M | -5.27% |
Jul 28, 2022 | 9.04M | 3.01% |
Jul 27, 2022 | 8.78M | 1.41% |
Jul 26, 2022 | 8.66M | -11.62% |
Jul 25, 2022 | 9.80M | -6.90% |
Jul 22, 2022 | 10.52M | 3.52% |
Jul 21, 2022 | 10.16M | -0.59% |
Jul 20, 2022 | 10.22M | -11.12% |
Jul 19, 2022 | 11.50M | -7.62% |
Jul 18, 2022 | 12.45M | -45.09% |
View and export this data all the way back to 2021.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition
Related Stocks
Company | Market Cap |
---|---|
Bone Biologics | 16.04M |
Diffusion Pharmaceuticals | 13.54M |
Pulmatrix | 15.68M |
RenovoRx | 18.59M |
Neovasc | 21.34M |
Immuron | 15.32M |
Tivic Health Systems | 18.29M |
Liminal BioSciences | 16.47M |
Celsion | 16.82M |